Table 2.
Group parameter | PD, n = 20 | HD, n = 20 | Pre, n = 36 | Controls, n = 26 | p value |
---|---|---|---|---|---|
PWV/ht (m/s) | 5.51 ± 0.68a,c | 6.07 ± 0.86a,b,d | 5.53 ± 0.69a,c | 4.85 ± 0.62 | p < 0.0001 |
sAF (10–2 AU) | 2.46 ± 0.72a,d | 2.61 ± 0.57a,d | 1.9 ± 0.46a,b,c | 1.33 ± 0.26 | p < 0.0001 |
LVM (g) | 92.5 ± 21.9 | 106.2 ± 32.3 | 94.2 ± 26.7 | 92.3 ± 20.5 | NS |
LVMI (g/m2,7) | 32.9 ± 5.5a,c,d | 37 ± 6.4a,b,d | 27.3 ± 6.6b,c | 26.4 ± 5.2 | p < 0.0001 |
Homocysteine (μmol/l) | 14.39 ± 1.88a,d | 15.83 ± 3.29a,d | 11.24 ± 2.74a | 7.64 ± 1.55 | p < 0.0001 |
PWV/ht pulse wave velocity indexed to height, sAF skin autofluorescence, LVMI left ventricular mass index
aPD, HD, Pre vs. control group
bHD, Pre vs. PD
cPD, Pre vs. HD
dPD, HD vs. Pre